Affiliation: University of Illinois College of Medicine, Rockford

Dr. Vishal Khatri obtained his PhD in Medical Biochemistry from the Maharashtra University of Health Sciences (India) in 2017 with emphasis on infectious disease, vaccine research, and development of biotherapeutics for chronic inflammation associated disorders (CIAD). Following his PhD, he moved to the University of Illinois College of Medicine at Rockford (USA) as a post-doctoral researcher with an extensive training in molecular biology, immunology, infectious diseases, and animal models for CIAD. At UIC, he is now working on the development of a vaccine for human lymphatic filariasis and successfully finished safety and protective efficacy trials in non-human primates. Currently, his focus is on development of helminth-derived recombinant biotherapeutics for colitis and type-1 diabetes, as well as developing an innovative nano-delivery system for biotherapeutics.